Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

204 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Persistent disease and recurrence in differentiated thyroid cancer patients with undetectable postoperative stimulated thyroglobulin level.
Nascimento C, Borget I, Al Ghuzlan A, Deandreis D, Chami L, Travagli JP, Hartl D, Lumbroso J, Chougnet C, Lacroix L, Baudin E, Schlumberger M, Leboulleux S. Nascimento C, et al. Among authors: chougnet c. Endocr Relat Cancer. 2011 Mar 3;18(2):R29-40. doi: 10.1677/ERC-10-0292. Print 2011 Apr. Endocr Relat Cancer. 2011. PMID: 21183629 Review.
[Refractory thyroid cancers].
Schlumberger M, Chougnet C, Baudin E, Leboulleux S; pour le réseau Tuthyref. Schlumberger M, et al. Among authors: chougnet c. Presse Med. 2011 Dec;40(12 Pt 1):1189-98. doi: 10.1016/j.lpm.2011.09.011. Epub 2011 Nov 9. Presse Med. 2011. PMID: 22078085 Review. French.
Therapeutic management of advanced adrenocortical carcinoma: what do we know in 2011?
Baudin E, Leboulleux S, Al Ghuzlan A, Chougnet C, Young J, Deandreis D, Dumont F, Dechamps F, Caramella C, Chanson P, Lanoy E, Borget I, Schlumberger M. Baudin E, et al. Among authors: chougnet c. Horm Cancer. 2011 Dec;2(6):363-71. doi: 10.1007/s12672-011-0094-2. Horm Cancer. 2011. PMID: 22161625 Free PMC article. Review.
Combination chemotherapy in advanced adrenocortical carcinoma.
Fassnacht M, Terzolo M, Allolio B, Baudin E, Haak H, Berruti A, Welin S, Schade-Brittinger C, Lacroix A, Jarzab B, Sorbye H, Torpy DJ, Stepan V, Schteingart DE, Arlt W, Kroiss M, Leboulleux S, Sperone P, Sundin A, Hermsen I, Hahner S, Willenberg HS, Tabarin A, Quinkler M, de la Fouchardière C, Schlumberger M, Mantero F, Weismann D, Beuschlein F, Gelderblom H, Wilmink H, Sender M, Edgerly M, Kenn W, Fojo T, Müller HH, Skogseid B; FIRM-ACT Study Group. Fassnacht M, et al. N Engl J Med. 2012 Jun 7;366(23):2189-97. doi: 10.1056/NEJMoa1200966. Epub 2012 May 2. N Engl J Med. 2012. PMID: 22551107 Free article. Clinical Trial.
Kinase inhibitors for advanced medullary thyroid carcinoma.
Schlumberger M, Massicotte MH, Nascimento CL, Chougnet C, Baudin E, Leboulleux S. Schlumberger M, et al. Among authors: chougnet c. Clinics (Sao Paulo). 2012;67 Suppl 1(Suppl 1):125-9. doi: 10.6061/clinics/2012(sup01)21. Clinics (Sao Paulo). 2012. PMID: 22584717 Free PMC article. Review.
Postradioiodine treatment whole-body scan in the era of 18-fluorodeoxyglucose positron emission tomography for differentiated thyroid carcinoma with elevated serum thyroglobulin levels.
Leboulleux S, El Bez I, Borget I, Elleuch M, Déandreis D, Al Ghuzlan A, Chougnet C, Bidault F, Mirghani H, Lumbroso J, Hartl D, Baudin E, Schlumberger M. Leboulleux S, et al. Among authors: chougnet c. Thyroid. 2012 Aug;22(8):832-8. doi: 10.1089/thy.2012.0081. Thyroid. 2012. PMID: 22853728
Treatment with sunitinib for patients with progressive metastatic pheochromocytomas and sympathetic paragangliomas.
Ayala-Ramirez M, Chougnet CN, Habra MA, Palmer JL, Leboulleux S, Cabanillas ME, Caramella C, Anderson P, Al Ghuzlan A, Waguespack SG, Deandreis D, Baudin E, Jimenez C. Ayala-Ramirez M, et al. Among authors: chougnet cn. J Clin Endocrinol Metab. 2012 Nov;97(11):4040-50. doi: 10.1210/jc.2012-2356. Epub 2012 Sep 10. J Clin Endocrinol Metab. 2012. PMID: 22965939 Free PMC article.
Early changes in carcinoembryonic antigen but not in calcitonin levels are correlated with the progression-free survival in medullary thyroid carcinoma patients treated with cytotoxic chemotherapy.
Hajje G, Borget I, Leboulleux S, Chougnet C, Al Ghuzlan A, Mirghani H, Caramella C, Hartl D, Schlumberger M, Baudin E. Hajje G, et al. Among authors: chougnet c. Eur J Endocrinol. 2012 Dec 31;168(2):113-8. doi: 10.1530/EJE-12-0771. Print 2013 Feb. Eur J Endocrinol. 2012. PMID: 23093698
204 results